Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
10-day PF-00232798 monotherapy in asymptomatic HIV-infected patients
2006-006821-15Phase 2Completed
- Sponsor
- Pfizer
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in human immunodeficiency virus infection (HIV) comparing PF-00232798 with Placebo (2 arms). Primary endpoint: HIV viral load. Started Mar 2007; status: completed.
02
Drugs
PF-232798
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2006-006821-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006821-15.